Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7E6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,208
Award facts
- Contract value 100% obligated
- $13,207.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 mL pens valued at $13,207.85 on December 17, 2025, with completion expected by December 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply to military and federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, supplies a comprehensive portfolio of medications and medical products to support federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Wegovy, a diabetes and weight management medication, aligns with the company's established role as a critical vendor in the DLA's pharmaceutical supply chain, which encompasses brand-name and generic drugs, vaccines, specialty medications, and medical devices across multiple therapeutic domains. The award demonstrates the company's continued capability to meet federal procurement requirements through competitive selection.
Quick answers
Who was awarded contract SPE2DR26FM7E6?
SPE2DR26FM7E6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FM7E6 worth?
The government has obligated $13,208 on SPE2DR26FM7E6.
Is contract SPE2DR26FM7E6 an order under another contract?
Yes. SPE2DR26FM7E6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7E6 competed?
The extent of competition for SPE2DR26FM7E6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award